These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 25301563

  • 1. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.
    Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.
    Oral Oncol; 2014 Dec; 50(12):1169-76. PubMed ID: 25301563
    [Abstract] [Full Text] [Related]

  • 2. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV.
    Mazul AL, Hartman C, Kramer J, White DL, Royse K, Raychaudhury S, Sandulache V, Ahmed ST, Richardson P, Sikora AG, Chiao E.
    Cancer Med; 2020 Dec; 9(24):9326-9335. PubMed ID: 33094910
    [Abstract] [Full Text] [Related]

  • 3. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection.
    Strojan P, Zadnik V, Šifrer R, Lanišnik B, Didanović V, Jereb S, Poljak M, Kocjan BJ, Gale N.
    Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3805-14. PubMed ID: 25542247
    [Abstract] [Full Text] [Related]

  • 4. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E, Buchanan P, Hinyard L, Osazuwa-Peters N, Schootman M, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2018 Aug 01; 144(8):727-737. PubMed ID: 30027284
    [Abstract] [Full Text] [Related]

  • 5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS, Sikora AG, Baxi SS, Morris LG.
    Cancer; 2013 May 15; 119(10):1832-7. PubMed ID: 23423883
    [Abstract] [Full Text] [Related]

  • 6. Human papilloma virus prevalence in HIV patients with head and neck squamous cell carcinoma.
    Picard A, Badoual C, Hourseau M, Halimi C, Pere H, Dib F, Barry B, Albert S.
    AIDS; 2016 May 15; 30(8):1257-66. PubMed ID: 26807970
    [Abstract] [Full Text] [Related]

  • 7. Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015.
    Carvajal LJ, Shing JZ, Vanegas JC, González E, Guillén D, Sierra MS, Hildesheim A, Porras C, Herrero R, Torres G, Shiels MS, Calderón A, Kreimer AR.
    Int J Cancer; 2023 May 15; 152(10):2052-2060. PubMed ID: 36650690
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Mazul AL, Hartman CM, Mowery YM, Kramer JR, White DL, Royse KE, Raychaudhury S, Sandulache VC, Ahmed ST, Zevallos JP, Richardson PA, Sikora AG, Chiao EY.
    Cancer; 2022 Sep 15; 128(18):3310-3318. PubMed ID: 35867552
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR, Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium.
    Cancer; 2018 Jan 01; 124(1):84-94. PubMed ID: 29053175
    [Abstract] [Full Text] [Related]

  • 12. Risk of human papillomavirus-associated cancers among persons with AIDS.
    Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.
    J Natl Cancer Inst; 2009 Aug 19; 101(16):1120-30. PubMed ID: 19648510
    [Abstract] [Full Text] [Related]

  • 13. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA, Lai LL.
    Cancer; 2017 Oct 15; 123(20):4013-4021. PubMed ID: 28608917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H, Eldenhed Alwan E, Roslin A, Wennerberg J, Forslund O.
    J Gen Virol; 2016 Nov 15; 97(11):2949-2956. PubMed ID: 27667722
    [Abstract] [Full Text] [Related]

  • 18. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.
    Wang XI, Thomas J, Zhang S.
    Ann Diagn Pathol; 2012 Jan 15; 16(1):7-12. PubMed ID: 22001331
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
    Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Hongyo T, Inohara H.
    Cancer Sci; 2014 Apr 15; 105(4):409-17. PubMed ID: 24521534
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of human papillomavirus-related head and neck cancer.
    Joseph AW, D'Souza G.
    Otolaryngol Clin North Am; 2012 Aug 15; 45(4):739-64. PubMed ID: 22793850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.